Audiological assessment of neonatal hyperbilirubinemia.
ABR
Hearing loss
Hyperbilirubinemia
Neonate
Journal
International journal of pediatric otorhinolaryngology
ISSN: 1872-8464
Titre abrégé: Int J Pediatr Otorhinolaryngol
Pays: Ireland
ID NLM: 8003603
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
received:
10
03
2020
revised:
15
05
2020
accepted:
15
05
2020
pubmed:
9
6
2020
medline:
15
12
2020
entrez:
8
6
2020
Statut:
ppublish
Résumé
To evaluate the hearing of infants with history of neonatal hyperbilirubinemia using ABR. A prospective randomized study carried on 100 infants whose hearing was assessed by ABR. Infants were allocated into two groups; case group which involve 60 infants with history of neonatal hyperbilirubinemia (bilirubin more than17 mg/dl and less than 30 mg/dl) and control group involve 40 healthy infants. Each group was divided into 3 groups based on their age i.e. ≤ 6 months, > 6-9 months &> 9-12 months. The evaluated variables were latency time & inter peak latency time. The mean latencies of wave III&V of ABR were significantly higher in the case group compared with the controls (P < 0.001) while the mean latencies of wave I did not show a significant difference between the two study groups (P > 0.05). The mean inter wave latencies I-III, I-V& III-V of ABR were significantly higher in the case group compared with the controls. There was a negative correlation between age and the studied variables. Hyperbilirubinemia have an adverse effect on neonatal hearing which was reflected by ABR parameters of this study.
Identifiants
pubmed: 32505932
pii: S0165-5876(20)30269-X
doi: 10.1016/j.ijporl.2020.110126
pii:
doi:
Substances chimiques
Bilirubin
RFM9X3LJ49
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
110126Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest No conflict of interest and nothing to disclose.